CSF GAP-43 levels are increased in Alzheimer’s disease patients compared with other neurodegenerative disorders such as Parkinson’s disease and frontotemporal dementia and may be useful in the differential diagnosis of the disease. Here, GAP43 is linked to Parkinson disease.